Scientific reports

Cureus

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP

International ophthalmology

[1] Relationship of Hypertensive Retinopathy with Mean Platelet Volume Among Hypertensive Patients.

[2] the relationship between microvascular complications and depression in patients with type 2 diabetes mellitus who use insulin

[3] evaluation of oct on retinopathy induced by tunicamycin in rats

[4] Intestinal perforation after intravitreal low dose ranibizumab injection for the treatment of type 1 retinopathy of prematurity: A case report

[5] Fabrication of resveratrol coated gold nanoparticles and investigation of their effect on diabetic retinopathy in streptozotocin induced diabetic rats.

[6] An Evaluation System of Fundus Photograph-Based Intelligent Diagnostic Technology for Diabetic Retinopathy and Applicability for Research.

[7] Strategies to Tackle the Global Burden of Diabetic Retinopathy: From Epidemiology to Artificial Intelligence.

[8] Treatment of central serous chorioretinopathy with topical NSAIDs

[9] Treatment of central serous chorioretinopathy with topical NSAIDs

[10] Treatment of central serous chorioretinopathy with topical NSAIDs

[11] Endogenous Clostridium perfringens Panophthalmitis with Potential Entry Port from Diverticulitis Exacerbated by Proliferative Diabetic Retinopathy

[12] Use of Expectation Disconfirmation Theory to Test Patient Satisfaction with Asynchronous Telemedicine for Diabetic Retinopathy Detection

[13] Body Mass Index: A Risk Factor for Retinopathy in Type 2 Diabetic Patients

[14] Awareness of diabetes and diabetic retinopathy among a group of diabetic patients in main public hospitals in Damascus, Syria during the Syrian crisis.

[15] Disease risk factor control and drug intervention in diabetic retinopathy

[16] Systemic Factors Related to Intraocular Levels of Interleukin-6 and Vascular Endothelial Growth Factor in Diabetic Retinopathy.

[17] Metabolic characterization of diabetic retinopathy: An ¹H-NMR-based metabolomic approach using human aqueous humor

[18] Retinal blood oxygen saturation and aqueous humour biomarkers in early diabetic retinopathy

[19] Multicolor imaging in central serous chorioretinopathy – a quantitative and qualitative comparison with fundus autofluorescence

[20] Visualizing Deep Learning Models for the Detection of Referable Diabetic Retinopathy and Glaucoma

[21] Prevalence and factors associated with diabetic retinopathy among diabetic patients at Arbaminch General Hospital, Ethiopia: Cross sectional study.

[22] Association of IGF1 and VEGFA polymorphisms with diabetic retinopathy in Pakistani population.

[23] -429 T/C and -374 T/A Polymorphisms in Receptor Advanced Glycation Endproducts (RAGE) gene in Type 2 Diabetic Patients with Diabetic Retinopathy at the Dr. Sardjito General Hospital Yogyakarta

[24] Risk of development of treated retinopathy of prematurity in very low birth weight infants.

[25] Glycated Haemoglobin and Diabetic Retinopathy in Type 2 Diabetic Patients in HRH Princess Maha Chakri Sirindhorn Medical Center

[26] Aiding the Diagnosis of Diabetic and Hypertensive Retinopathy Using Artificial Intelligence-Based Semantic Segmentation.

[27] Vitrectomy for proliferative diabetic retinopathy

[28] Relationship of Hypertensive Retinopathy with Mean Platelet Volume Among Hypertensive Patients.

[29] Identifying central serous chorioretinopathy biomarkers in coexisting diabetic retinopathy: a multimodal imaging study.

[30] Artificial intelligence with deep learning technology looks into diabetic retinopathy screening

[31] Intravitreal Aflibercept for Retinal Nonperfusion in Proliferative Diabetic Retinopathy: Outcomes from the Randomized RECOVERY Trial.

[32] [Fluorescence Angiography-assisted Management of Recurrences in Aggressive Posterior Retinopathy of Prematurity (APROP) after Intravitreal Monotherapy with 0.312 mg Bevacizumab].

[33] Changes in components of the neurovascular unit in the retina in a rat model of retinopathy of prematurity.

[34] Characteristics of 'sawtooth shunt' following anti-vascular endothelial growth factor for aggressive posterior retinopathy of prematurity.

[35] Functional result and visual outcome in early versus conventional treatment of retinopathy of prematurity.

[36] Clinical Predictors of Diabetic Retinopathy Progression; A Systematic Review.

[37] The prevalence and risk factors of diabetic retinopathy in selected primary care centers during the 3-year screening intervals.

[38] The prevalence and risk factors of diabetic retinopathy in selected primary care centers during the 3-year screening intervals

[39] QUANTITATIVE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY FEATURES FOR OBJECTIVE CLASSIFICATION AND STAGING OF DIABETIC RETINOPATHY.

[40] Visual Field Changes Over 5 Years in Patients Treated With Panretinal Photocoagulation or Ranibizumab for Proliferative Diabetic Retinopathy.

[41] Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial.

[42] Oxidative Stress, Ocular Disease and Diabetes Retinopathy.

[43] Hydroxychloroquine Retinopathy in the Era of Advanced Imaging Modalities

[44] Additional Analyses to Confirm Relationship of Hydroxychloroquine Blood Levels to Retinopathy: Comment on the Article by Petri et al

[45] Hydroxychloroquine Blood Levels Predict Hydroxychloroquine Retinopathy

[46] Hydroxychloroquine Induced Retinopathy: A Case Series

[47] Vision-related quality of life and visual function following vitrectomy for proliferative diabetic retinopathy

[48] Retinal Nerve Fiber Layer Thickness in Early-Stage Diabetic Retinopathy With Vitamin D Deficiency

[49] [Visual function analysis of diabetic retinopathy using a contrast sensitivity analyser and usefulness of nicardipine hydrochloride]

[50] Contrast sensitivity among patients with birdshot chorioretinopathy

[51] Insights into stem cell therapy for diabetic retinopathy: A bibliometric and visual analysis

[52] incidence of type-1 retinopathy of prematurity in premature babies born small for gestational age

[53] relevant risk factors analysis of diabetic retinopathy in patients with type 2 diabetes mellitus from community

[54] intravitreal bevacizumab in aggressive posterior retinopathy of prematurity

[55] angiogenic and vasculogenic factors in the vitreous from patients with proliferative diabetic retinopathy

[56] the association between diabetic retinopathy and levels of ischemia-modified albumin, total thiol, total antioxidant capacity, and total oxidative stress in serum and aqueous humor

[57] “oxygen with love” and diode laser treatment decreases comorbidity and avoidable blindness due to retinopathy of prematurity: results achieved in the past 12 years

[58] neutrophil/lymphocyte ratio and mean platelet volume in central serous chorioretinopathy

[59] incidence of retinopathy of prematurity in a tertiary care center of northeast india

[60] ranibizumab in patients with dense cataract and proliferative diabetic retinopathy with rubeosis

[61] antiretinal antibody- proven autoimmune retinopathy

[62] intravenous sodium fluorescein enhances the visibility of vitreous during vitrectomy surgery for diabetic retinopathy fluoresceína sódica intravenosa aumenta a visibilidade do vítreo durante a cirurgia de vitrectomia para retinopatia diabética

[63] effect of ranirestat, a new aldose reductase inhibitor, on diabetic retinopathy in sdt rats

[64] update on diagnosis and treatment of diabetic retinopathy: a consensus guideline of the working group of ocular health (spanish society of diabetes and spanish vitreous and retina society)

[65] incidencia de la retinopatía de la prematuridad incidence of retinopathy of prematurity

[66] the combined extract of purple waxy corn and ginger prevents cataractogenesis and retinopathy in streptozotocin-diabetic rats

[67] the association of type 2 diabetes mellitus with cerebral gray matter volume is independent of retinal vascular architecture and retinopathy

[68] newly diagnosed diabetes mellitus patients presenting with proliferative diabetic retinopathy as an initial sign

[69] retro-mode imaging of fibrovascular membrane in proliferative diabetic retinopathy after intravitreal bevacizumab injection

[70] combined surgery for neovascular angle-closure glaucoma secondary to proliferative diabetic retinopathy

[71] roles of elevated intravitreal il-1β and il-10 levels in proliferative diabetic retinopathy

[72] curative effect of extra-panretinal photocoagulation on proliferative diabetic retinopathy during vitreous operation

[73] community care for diabetic retinopathy and glaucoma in india: a panel discussion

[74] spontaneous closure of a full-thickness macular hole associated with proliferative diabetic retinopathy and persistent vitreomacular traction

[75] pattern visual evoked potential changes in diabetic patients without retinopathy

[76] radiation optic neuropathy and retinopathy with low dose (20 gy) radiation treatment

[77] role of electrophysiology in the early diagnosis and follow-up of diabetic retinopathy

[78] epigenetic modifications and diabetic retinopathy

[79] screening for diabetic retinopathy: the optometrist’s perspective

[80] comparing carotid intima-media thickness in type 2 diabetes between patients with and without retinopathy

[81] phytochemicals: target-based therapeutic strategies for diabetic retinopathy

[82] intravitreal ranibizumab for stage iv proliferative sickle cell retinopathy: a first case report

[83] noninvasive retinal markers in diabetic retinopathy: advancing from bench towards bedside

[84] a socioeconomic and behavioral survey of patients with difficult-to-control type 2 diabetes mellitus reveals an association between diabetic retinopathy and educational attainment

[85] antioxidative stress effect of probucol for nonproliferative diabetic retinopathy

[86] assessment of choroidal thickness of central serous chorioretinopathy by optical coherence tomography with enhanced depth imaging

[87] abnormal complement activation and inflammation in the pathogenesis of retinopathy of prematurity

[88] a case of uveal colobomas showing marked left-right difference in diabetic retinopathy

[89] comparative study of visual functions in premature pre-school children with and without retinopathy of prematurity

[90] diabetic retinopathy: an epidemic at home and around the world

[91] pronerve growth factor induces angiogenesis via activation of trka: possible role in proliferative diabetic retinopathy

[92] seizure related valsalva-like retinopathy

[93] macular integrity assessment and fixation analysis in chronic central serous chorioretinopathy

[94] macular ischaemia as a marker for nephropathy in diabetic retinopathy.

[95] neuroprotection as a therapeutic target for diabetic retinopathy

[96] foveal slope measurements in diabetic retinopathy: can it predict development of sight-threatening retinopathy? sankara nethralaya diabetic retinopathy epidemiology and molecular genetics study (sn-dreams ii, report no 8)

[97] clinical evidence and potential mechanisms of chinese medicines for the treatment of diabetic retinopathy

[98] system of the ophthalmologic help premature children with retinopathy of prematurity in the central region of russia

[99] nd:yag laser for preretinal hemorrhage in diabetic retinopathy

[100] differentially expressed micrornas in the development of early diabetic retinopathy

[101] diabetic retinopathy: a new approach to drug treatment